易方达标普生物科技美元现汇C(012867)
动态评分： 6.13分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2024-06-30 | MRNA | Moderna Inc | 买入 | 366.86 | 1.16% |
| 2024-06-30 | IMGN | ImmunoGen Inc | 卖出 | 365.05 | 1.15% |
| 2024-06-30 | CYTK | Cytokinetics Inc | 买入 | 355.01 | 1.12% |
| 2024-06-30 | MRTX | Mirati Therapeutics Inc | 卖出 | 350.41 | 1.11% |
| 2024-06-30 | CYTK | Cytokinetics Inc | 卖出 | 347.48 | 1.1% |
| 2024-06-30 | AKRO | Akero Therapeutics Inc | 卖出 | 315.4 | 1% |
| 2024-06-30 | PTCT | PTC Therapeutics Inc | 卖出 | 303.27 | 0.96% |
| 2024-06-30 | ARQT | Arcutis Biotherapeutics Inc | 买入 | 301.52 | 0.95% |
| 2024-06-30 | ALT | Altimmune Inc | 买入 | 298.29 | 0.94% |
| 2024-06-30 | BHVN | Biohaven Ltd | 卖出 | 285.29 | 0.9% |
| 2024-06-30 | CCCC | C4 Therapeutics Inc | 买入 | 254.22 | 0.8% |
| 2024-06-30 | KRYS | Krystal Biotech Inc | 卖出 | 248.92 | 0.79% |
| 2024-06-30 | ALNY | Alnylam Pharmaceuticals Inc | 买入 | 247.04 | 0.78% |
| 2024-06-30 | INBX | Inhibrx Biosciences Inc | 卖出 | 236.01 | 0.75% |
| 2024-06-30 | BCRX | BioCryst Pharmaceuticals Inc | 卖出 | 220.68 | 0.7% |
| 2024-06-30 | TWST | Twist Bioscience Corp | 卖出 | 221.62 | 0.7% |
| 2024-06-30 | RXRX | Recursion Pharmaceuticals Inc-A | 卖出 | 221.21 | 0.7% |
| 2024-06-30 | NTRA | Natera Inc | 卖出 | 215.11 | 0.68% |
| 2024-06-30 | ARWR | Arrowhead Pharmaceuticals Inc | 卖出 | 212.82 | 0.67% |
| 2024-06-30 | RVMD | Revolution Medicines Inc | 卖出 | 207.08 | 0.66% |
公告&资料
